98 related articles for article (PubMed ID: 4624674)
1. A starfish hemolymph factor which activates vertebrate complement in the presence of cobra venom factor.
Day N; Geiger H; Finstad J; Good RA
J Immunol; 1972 Jul; 109(1):164-7. PubMed ID: 4624674
[No Abstract] [Full Text] [Related]
2. Bypass-activation of the complement system starting with C3. I. Generation and function of an enzyme from a factor of guinea-pig serum and cobra venom.
Bitter-Suermann D; Dierich M; König W; Hadding U
Immunology; 1972 Sep; 23(3):267-81. PubMed ID: 4214761
[TBL] [Abstract][Full Text] [Related]
3. Complement-unlike hemolytic activity in lobster hemolymph.
Hall JL; Rowlands DT; Nilsson UR
J Immunol; 1972 Oct; 109(4):816-23. PubMed ID: 4627511
[No Abstract] [Full Text] [Related]
4. Specific hemagglutinin and a modulator of complement in cockroach hemolymph.
Anderson RS; Day NK; Good RA
Infect Immun; 1972 Jan; 5(1):55-9. PubMed ID: 4656356
[TBL] [Abstract][Full Text] [Related]
5. Complement as a regulator of interactions between immune complexes and cell membranes.
Miller GW; Nussenzweig V
J Immunol; 1974 Aug; 113(2):464-9. PubMed ID: 4845664
[No Abstract] [Full Text] [Related]
6. Kinetic analysis of chemotactic factor generation in human serum via activation of the classical and alternate complement pathways.
Gallin JI; Clark RA; Frank MM
Clin Immunol Immunopathol; 1975 Jan; 3(3):334-46. PubMed ID: 1088938
[No Abstract] [Full Text] [Related]
7. Proceedings: Role of membrane-derived fatty acids for haemolysis by phospholipase A and bovine serum albumin (BSA) or direct lytic factor of cobra venom (DLF).
Damerau B
Naunyn Schmiedebergs Arch Pharmacol; 1974; 282(Suppl):suppl 282:R16. PubMed ID: 4276534
[No Abstract] [Full Text] [Related]
8. Humoral mediators of chemotaxis of mononuclear leukocytes.
Hausman MS; Snyderman R; Mergenhagen SE
J Infect Dis; 1972 Jun; 125(6):595-602. PubMed ID: 5037013
[No Abstract] [Full Text] [Related]
9. In vitro neutralization of the Shwartzman-inducing activity of endotoxins by immune serum.
Végh P; Takáts I; Kováts TG
Immunology; 1970 Jul; 19(1):41-6. PubMed ID: 4922029
[TBL] [Abstract][Full Text] [Related]
10. Failure of cobra venom factor to prevent the generalized Shwartzman reaction and loss of renal cortical fibrinolytic activity.
Bergstein JM; Michael AF
Am J Pathol; 1974 Jan; 74(1):19-31. PubMed ID: 4588307
[TBL] [Abstract][Full Text] [Related]
11. Serum proteins involved in decay and regeneration of cobra venom factor-dependent complement activation.
Fearon DT; Austen KF; Ruddy S
J Immunol; 1973 Dec; 111(6):1730-6. PubMed ID: 4796101
[No Abstract] [Full Text] [Related]
12. Effects of fraction I from Yersinia pestis on phagocytosis in vitro.
Williams RC; Gewurz H; Quie PG
J Infect Dis; 1972 Sep; 126(3):235-41. PubMed ID: 4559742
[No Abstract] [Full Text] [Related]
13. Inhibition of endotoxic lipopolysaccharide-mediated platelet aggregation by cobra venom anticomplementary factor.
Fong JS; White JG; Good RA
Blood; 1974 Sep; 44(3):399-409. PubMed ID: 4604614
[No Abstract] [Full Text] [Related]
14. Congenital and experimentally induced complement deficiency in rabbits.
Fong JS; Good RA
Birth Defects Orig Artic Ser; 1975; 11(1):571-6. PubMed ID: 125122
[TBL] [Abstract][Full Text] [Related]
15. Inhibition of immune precipitation by complement.
Schifferli JA; Bartolotti SR; Peters DK
Clin Exp Immunol; 1980 Nov; 42(2):387-94. PubMed ID: 6781802
[TBL] [Abstract][Full Text] [Related]
16. Complement and complement-like activity in lower vertebrates and invertebrates.
Day NK; Gewurz H; Johannsen R; Finstad J; Good RA
J Exp Med; 1970 Nov; 132(5):941-50. PubMed ID: 5470510
[TBL] [Abstract][Full Text] [Related]
17. Immune hemolysis and a basic peptide from cobra venom.
Okada H; Campbell W
J Immunol; 1974 Nov; 113(5):1647-9. PubMed ID: 4472944
[No Abstract] [Full Text] [Related]
18. Activation of the alternative (properdin) pathway by divalent cations.
Lew FT; Yukiyama Y; Waks HS; Osler AG
J Immunol; 1975 Sep; 115(3):884-8. PubMed ID: 807649
[TBL] [Abstract][Full Text] [Related]
19. In vivo abrogation of serum C3 and C5 by administration of cobra venom factor and heterologous anti-C3.
Drake WP; Pokorney DR; Mardiney MR
J Immunol Methods; 1974 Dec; 6(1-2):61-72. PubMed ID: 4215835
[No Abstract] [Full Text] [Related]
20. Cobra venom factor-induced activation of the complement system: developmental, experimental and clinical considerations.
Gewurz H; Pickering RJ; Day NK; Good RA
Int Arch Allergy Appl Immunol; 1971; 40(1):47-58. PubMed ID: 5102089
[No Abstract] [Full Text] [Related]
[Next] [New Search]
